Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 06, 2019; 93 (6) Disputes & Debates: Editors' Choice

Editors' note: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment

James E. Siegler, Steven Galetta
First published August 5, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007903
Steven Galetta
MD, FAAN
Roles: Section Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Siegler III
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Galetta
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Editors' note: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment
James E. Siegler, Steven Galetta
Neurology Aug 2019, 93 (6) 277; DOI: 10.1212/WNL.0000000000007903

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
35

Share

  • Article
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

In their prospective observational study of 166 survivors of cardiac arrest with anoxic brain injury, Beretta and colleagues categorized patients according to 1 of 4 mutually exclusive EEG patterns: (1) benign, (2) refractory status epilepticus (RSE), (3) generalized periodic discharges (GPDs), or (4) discontinuous/unreactive. The investigators assessed long-term survival and functional outcome based on a minimum of 5 days of EEG monitoring and other clinical and serologic biomarkers. In response, Dr. Nitin Sethi stresses how EEG patterns may vary with time following anoxic brain injury. Dr. Beretta agrees that EEG patterns are likely to fluctuate with time (and treatment) and, for this reason, classified patients according to the most severe pattern observed. Interrater agreement for each of these EEG categories was high (κ = 0.92). Importantly, patients with discontinuous or unreactive background activity or GPDs had extremely poor outcomes (mortality rates of 85% and 98%, respectively), whereas those with RSE had a 53% chance of long-term survival and 44% chance of a good functional outcome. Dr. Sethi also raises several concerns as to when one should initiate EEG monitoring and at what point one should use this electrophysiological data for neuroprognostication. In this investigation, Dr. Beretta and colleagues found a mean duration of RSE to be 4.7 days and therefore suggested 5 days as a reasonable initial assessment point for prognostication. This information may be helpful in the planning of future clinical trials, especially because a pattern of RSE may be associated with a better prognosis than GPD or discontinuous activity.

In their prospective observational study of 166 survivors of cardiac arrest with anoxic brain injury, Beretta and colleagues categorized patients according to 1 of 4 mutually exclusive EEG patterns: (1) benign, (2) refractory status epilepticus (RSE), (3) generalized periodic discharges (GPDs), or (4) discontinuous/unreactive. The investigators assessed long-term survival and functional outcome based on a minimum of 5 days of EEG monitoring and other clinical and serologic biomarkers. In response, Dr. Nitin Sethi stresses how EEG patterns may vary with time following anoxic brain injury. Dr. Beretta agrees that EEG patterns are likely to fluctuate with time (and treatment) and, for this reason, classified patients according to the most severe pattern observed. Interrater agreement for each of these EEG categories was high (κ = 0.92). Importantly, patients with discontinuous or unreactive background activity or GPDs had extremely poor outcomes (mortality rates of 85% and 98%, respectively), whereas those with RSE had a 53% chance of long-term survival and 44% chance of a good functional outcome. Dr. Sethi also raises several concerns as to when one should initiate EEG monitoring and at what point one should use this electrophysiological data for neuroprognostication. In this investigation, Dr. Beretta and colleagues found a mean duration of RSE to be 4.7 days and therefore suggested 5 days as a reasonable initial assessment point for prognostication. This information may be helpful in the planning of future clinical trials, especially because a pattern of RSE may be associated with a better prognosis than GPD or discontinuous activity.

Footnotes

  • Author disclosures are available upon request (journal{at}neurology.org).

  • See letter

  • See response

  • © 2019 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
  • Info & Disclosures
Advertisement

Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020

Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft

► Watch

Related Articles

  • Reader response: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment
  • Author response: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment
    Simone Beretta, Anna Coppo, Elisa Bianchi et al.
    Neurology, October 31, 2018
  • Article
    Standardized EEG interpretation accurately predicts prognosis after cardiac arrest
    Erik Westhall, Andrea O. Rossetti, Anne-Fleur van Rootselaar et al.
    Neurology, February 10, 2016
  • Articles
    Electroencephalographic monitoring during hypothermia after pediatric cardiac arrest
    N. S. Abend, A. Topjian, R. Ichord et al.
    Neurology, June 01, 2009
  • Review
    Early myoclonus following anoxic brain injury
    Alexandra S. Reynolds, Benjamin Rohaut, Manisha G. Holmes et al.
    Neurology: Clinical Practice, May 23, 2018
Neurology: 101 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise